TechnologyBig Pharma says AI is cutting early drug discovery timelines by as much as halfGSK, Novartis, Eli Lilly, Novo Nordisk, AstraZeneca, Sanofi and Bristol Myers Squibb told Reuters that AI has cut the time needed to produce new molecules and move them into the clinic by up to half, as Anthropic pushes deeper into drug discovery.Technology08:00Automated21 Nov2 min readAutomated